For patient characteristics of smoking status; family history of premature heart disease; and the use of beta-blockers, ACE inhibitors, and the aldosterone antagonists spironolactone and eplenerone, <30% of studies were closely matched to the reference population. Here, ACE is linked to heart disorder.